Filter your results
- 3
- 3
- 3
- 1
- 1
- 1
- 3
- 2
- 2
- 1
- 1
- 1
- 1
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Time 2EVOLVE: predicting efficacy of engineered T-cells – how far is the bench from the bedside?Journal for Immunotherapy of Cancer, 2022, 10 (5), pp.e003487. ⟨10.1136/jitc-2021-003487⟩
Journal articles
hal-03869284v1
|
||
|
Preclinical Evaluation of a Cell-Based Gene Therapy Using the Sleeping Beauty Transposon System in Choroidal NeovascularizationMolecular Therapy - Methods and Clinical Development, 2019, 15, pp.403-417. ⟨10.1016/j.omtm.2019.10.013⟩
Journal articles
hal-03292059v1
|
||
|
Long-Term PEDF Release in Rat Iris and Retinal Epithelial Cells after Sleeping Beauty Transposon-Mediated Gene DeliveryMolecular Therapy - Nucleic Acids, 2017, 9, ⟨10.1016/j.omtn.2017.08.001⟩
Journal articles
hal-03292049v1
|